Please assess the completion status of the following clinical trial:

Trial Title: Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Postpartum women who are interested in pharmacologic lactation suppression~2. Women over the age of 18~Exclusion Criteria:~1. Women with known sensitivity to vitamin B6 or Cabergoline~2. Women with hypertensive Disorders or contraindication to Cabergoline.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Administration of Cabergoline (Type: ACTIVE_COMPARATOR): one dose of 1mg, up to 24 hours postpartum, or 0.25 mg twice a day for two days
- Administration of Vitamin B6 (Type: ACTIVE_COMPARATOR): 200 mg X 3 per day for a week

Based on this trial design, predict the completion outcome and termination type (if applicable).